POLD1 and malignant colon neoplasm: Mutations in KIAA1217, POLD1, PIEZO1, NBEAL2, DDX17, and PARP14 were significantly more prevalent in patients with colon cancer and PRShigh than in those with PRSlow (Figure 5c).